Tandem Diabetes Care

Tandem Diabetes Care, Inc. is a medical device company headquartered in San Diego, California, focused on developing and commercializing innovative insulin delivery systems for individuals with insulin-dependent diabetes. Its flagship product, the t:slim X2 insulin delivery system, features a pump, a 300-unit disposable insulin cartridge, and an infusion set, with advanced options such as Basal-IQ and Control-IQ technologies. The company also offers a web-based data management application, t:connect, to help users and healthcare providers manage diabetes therapy effectively. In addition to the t:slim X2, Tandem has recently introduced the Mobi insulin pump and is working on a tubeless pump. A significant portion of its revenue comes from the sale of insulin pumps and disposable infusion sets. Tandem maintains a development agreement with Dexcom, Inc. and continues to explore connected health solutions, including the Sugarmate mobile app. Founded in 2006, Tandem Diabetes Care aims to enhance the quality of life for diabetes patients through its innovative products.

Mark Novara

EVP and Chief Commercial Officer

Leigh Vosseller

Executive Vice President, CFO and Treasurer

2 past transactions

CeQur

Series C in 2021
CeQur SA focuses on creating innovative insulin delivery systems aimed at improving the management of type 2 diabetes. The company is developing the CeQur Insulin Infuser, a discreet and user-friendly device that allows patients to receive both basal and bolus insulin over a three-day period. This technology helps facilitate intensive insulin therapy, offering individuals flexibility and alleviating the need for multiple daily injections. Founded in January 2008 as a spin-off from Danfoss A/S, CeQur is headquartered in Montreux, Switzerland, with additional operations in Nordborg, Denmark, and Marlborough, Massachusetts. Through its products, CeQur seeks to enhance the quality of life for diabetes patients by simplifying insulin delivery and promoting better adherence to therapy.

Sugarmate

Acquisition in 2020
Sugarmate Inc. develops a companion application for users of the Dexcom G5/G6 continuous glucose monitoring system, enabling individuals to effectively manage their diabetes. The application provides real-time data and alerts, notifying users through phone calls and text messages when glucose levels drop below normal. It offers customizable alerts for various scenarios, including fluctuations in glucose levels, and allows users to track their food intake, exercise, insulin, and medication. Additionally, the application can synchronize with other food tracking platforms and utilizes voice recognition to access nutritional information. Sugarmate Inc. serves a diverse audience, including patients, family members, and healthcare professionals, facilitating better diabetes management. Originally known as Wild Village LLC, the company was incorporated in 2015 and is based in New York, operating as a subsidiary of Tandem Diabetes Care, Inc. since 2020.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.